Japan’s Approval of Stem-Cell Treatment for Spinal-Cord Injury Concerns Scienitsts
January 25, 2019
(Nature) – But independent researchers warn that the approval is premature. Ten specialists in stem-cell science or spinal-cord injuries, who were approached for comment by Nature and were not involved in the work or its commercialization, say that evidence that the treatment works is insufficient. Many of them say that the approval for the therapy, which is injected intravenously, was based on a small, poorly designed clinical trial.